Amphetamines are recognised for being metabolized, to a point, by cytochrome P450 2D6 (CYP2D6) and display small inhibition of CYP2D6 metabolism; probable to get a pharmacokinetic interaction exists with coadministration of CYP2D6 inhibitors which may raise risk with improved exposure to amphetamines; in these conditions, think about option non-serotonergic drug https://miltonr769bcb4.laowaiblog.com/profile